alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.2

CERTIFICATIONS

I, Michael Schmidt, certify that:

1. I have reviewed this Form 10-Q of Language Line Holdings, Inc.;

2. Based on my knowledge, this report does not contain
any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrants
other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

c)
Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting;

5.
The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of
directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control
over financial reporting.



|                     |  |                                                      
|-------------------- |  | -----------------------------------------------------
|Date: August 7, 2008
|                     | 
|By:                  |  | /s/ Michael Schmidt                                  
|                     |  | Michael Schmidt Chief Financial Officer and
Secretary
Exhibit 32.2
 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
 In connection with the Quarterly Report of Horizon Lines, Inc. (the Company) on Form 10-Q for
the period ending June 22, 2008 as filed with the Securities and
Exchange Commission, and as amended by the Quarterly Report on Form
10-Q/A filed with the Securities and Exchange Commission on the date
hereof (the Report), I, Michael T. Avara, Senior Vice President and Chief Financial Officer of
the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the
Sarbanes-Oxley Act of 2002, that:(1)
    
    The Report fully complies with the requirements
of Section 13(a) or 15(d), as applicable, of the
Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly
presents, in all material respects, the
financial condition and results of operations of
the Company.
 /s/ MICHAEL T. AVARAMichael T. AvaraSenior Vice President and Chief Financial Officer
(Principal Financial Officer)
Petition for Writ of Mandamus Denied and Memorandum Opinion filed

Ju ly 12 , 2022.

In The



## Fourteenth Court of Appeals

NO. 14

- 21

- 00503

- CV

IN RE KURARAY AMERIC A, INC. , Relator

ORIGINAL PROCEEDING WRIT OF MANDAMUS 234th District Court Harris County, Texas Trial Court Cause No. 2018

- 62973



### MEMORANDUM OPINION

R elator Kuraray America, Inc. filed a petition for writ of m andamus and emergency motion for temporary relief in this Court

. See Tex. Gov’t Code Ann. § 22.221; see also Tex. R. App. P. 52. In the peti t ion, relator asks this Court to compel the Honorable Lauren Reeder, presiding judge of the 234th District Court
of Harris County
, to “vacate its June 25 and August 19, 2021 order s , deny Plaintiffs’ and Providers’ Motions to Quash Production, and grant Kur a ray2

America’s Motion to Reconsider Production of Medical Reimbursement Discovery and to Compel.”

Relator has not established that it is entitled to mandamus relief. Accordingly, we deny relator’s petition for writ of mandamus. Additionally, our October 1 4, 2021 stay is lif ted.

PER CURIAM

Panel c onsists of Justices Jewell, Bourliot, and Zimmerer.
EX PARTE IT ALL, INC., It All Leasing, L.L.C., Roller Knights, L.L.C., and Jim Wilhelm

1160942 (2160154)

Supreme Court of Alabama.

September 15, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Cert. denied.
1 

# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 17-1747V Filed: September 28, 2018

UNPUBLISHED

LARRY NELSON,

Petitioner,

v.

SECRETARY OF HEALTH AND HUMAN SERVICES,

Respondent. Special Processing Unit (SPU); Ruling on Entitlement; Concession; Table Injury; Infl uenza (Flu) Vaccine; Guillain-Barre Syndrome (GBS)

Randall G. Knutson, Knutson & Casey Law Firm, Mankato, MN , for petitioner. Glenn Alexander MacLeod, U.S. Department of Justice, Washington, DC, for
respondent.

RULING ON ENTITLEMENT 1

Dorsey , Chief Special Master:

On November 7, 2017, Larry Nels on (“petitioner”) filed a petition for compensation under the National Vaccine Inju ry Compensation Program, 42 U.S.C. §300aa-10, et seq.

, 2 (the “Vaccine Act”). Petitioner alleges that he suffered from Guillain-Barré syndrome (“GBS”) as a result of an influenza (“flu”) vaccine he received on September 20, 2016. Petition at 1. The case was assigned to the Special Processing Unit of the Offi ce of Special Masters.

On September 27, 2018, respondent filed his Rule 4(c) report in which he concedes that petitioner is entitled to comp ensation in this case. Respondent’s Rule 4(c) Report at 1. Specifically, respondent “petitioner ha s satisfied the criteria set forth in

1 Because this unpublished ruling contains a reaso ned explanation for the action in this case, the undersigned intends to post it on the United States Cour t of Federal Claims' website, in accordance with

the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other inform ation, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, t he undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Ac t will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012).2 Vaccine Injury Table (Table) and the Qualific ations and Aids to Interpretation (QAI), which afford petitioner a presumption of va ccine causation if the onset of GBS occurs between three and forty-two days after a seas onal flu vaccination, and there is no apparent alternative cause.” Id. at 6.

In view of respondent’s positio n and the evidence of record, the undersigned finds that petitioner is entitled to compensation.

IT IS SO ORDERED.

s/Nora Beth Dorsey Nora Beth Dorsey Chief Special Master
Willie GRIFFIN, Petitioner, v. STATE of Florida, Respondent.

No. 1D19-0160

District Court of Appeal of Florida, First District.

May 29, 2019

Willie Griffin, pro se, Petitioner.

Ashley Moody, Attorney General, Tallahassee, for Respondent.

Per Curiam.

The petition alleging ineffective assistance of appellate counsel is denied on the merits.

Wolf, Kelsey, and Winokur, JJ., concur.
Exhibit
32.1





CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED


PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of Smartmetric, Inc. (the “Company”) on
Form 10-Q for the period ended December 31, 2008, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Colin Hendrick,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section
1350 of the Sarbanes-Oxley Act of 2002, that:





(1)
            The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934; and(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.





The
foregoing certification is being furnished solely to accompany the Report
pursuant to 18 U.S.C. section 1350 and is not being filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before or
after the date hereof, regardless of any general incorporation language in such
filing.




Dated: February
      17,
      2009
                By:
                /s/ Colin
      HendrickColin
      HendrickPresident
      (Principal Executive Officer)
1

COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER

Appellate case name: Dwayne Rayshaun Wilson v. Empire Towing LLC and ATC 

Auto Storage LLC

Appellate case number: 01-18-01145-CV

Trial court case number: 1117336

Trial court: County Civil Court at Law No. 2 of Harris County

Appellant, Dwayne Rayshaun Wilson, has filed a notice of appeal of the trial 

court’s final order signed on December 14, 2018. The clerk’s record filed in this Court 

includes his “Unsworn Declaration of Inability to Pay.” See TEX. R. CIV. P. 145(a); see 

also TEX. R. CIV. P. 502.3. And, the record filed in this Court does not reflect that any 

motion to require appellant to pay costs or any contest to appellant’s declaration was 

filed. See TEX. R. CIV. P. 145(a), (f). Accordingly, the Clerk of this Court is directed 

to make an entry in this Court’s records that appellant is allowed to proceed on 

appeal without payment of costs. See TEX. R. CIV. P. 145(a); TEX. R. APP. P. 20.1.

Judge’s signature: /s/ Julie Countiss

  Acting individually  Acting for the Court

Date: ___February 5, 2019_
EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
           PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     I, Elena Pochapski, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant  to  Section  906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report  of  Siberian  Energy  Group Inc. on Form 10-QSB for the quarterly period
ended  March  31, 2005, fully complies with the requirements of Section 13(a) or
15(d)  of  the Securities Exchange Act of 1934 and that information contained in
such  Form  10-QSB  fairly  presents  in  all  material  respects  the financial
condition  and  results  of  operations  of  Siberian  Energy  Group  Inc.

Date:  May 18, 2005

                                        By: /s/ Elena Pochapski
                                            -------------------
                                            Elena Pochapski
                                            Chief Financial Officer

<PAGE>
Amendment to Indemnification Agreement



 Exhibit 10.1 
  
 AMENDMENT TO INDEMNIFICATION AGREEMENT 
  
 This Amendment to Indemnification Agreement (this “Amendment”) is dated as of January 13, 2003 among Embrex, Inc.
(the “Company”) and David L. Castaldi. 
  
 WITNESSETH:

  
 WHEREAS, the Company entered into the Indemnification
Agreement dated as of April 1, 1999 (the “Indemnification Agreement”) among the Company and the Directors of the Company on such date; 
  
 WHEREAS, the Indemnification Agreement was amended by an Amendment dated as of May 17, 2001 and an Amendment dated as of February 14, 2002, in order to
add certain new Directors as parties thereto; 
  
 WHEREAS, on
January 13, 2003, Mr. David L. Castaldi was elected to the Board of Directors of the Company; and 
  
 WHEREAS, the Company wishes to add Mr. Castaldi as a party to the Indemnification Agreement; 
  
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties hereto agree as follows: 
  
 1. The Indemnification
Agreement is hereby amended, effective as of January 13, 2003, to add and include David L. Castaldi as an “Indemnitee” under and as defined in the Indemnification Agreement. The Indemnification Agreement is hereby further amended by adding
the following at the end of Schedule A to the Indemnification Agreement: 
  
 “David L. Castaldi 
 11 Bellingham Road 
 Chestnut Hill, MA 02467-3229” 
  
 2. This Amendment is limited as specified and shall not constitute an amendment, modification or waiver of any other provision of the Indemnification
Agreement. 
  
 3. From and after the date hereof, all references
to the Indemnification Agreement shall be deemed to be references to the Indemnification Agreement as amended hereby. 







 4. This Amendment may be executed in any number of counterparts and by the different parties hereto on
separate counterparts, each of which counterparts when executed and delivered shall be an original, but all of which shall together constitute one and the same instrument. This Amendment may be executed and delivered by telecopy or facsimile
machine. 
  
 IN WITNESS WHEREOF, each of the parties hereto has
duly executed this Amendment on or about May 15, 2003 with an effective date as of January 13, 2003. 
  

	EMBREX, INC.
		
	 By:
	 	 /s/    RANDALL L.
MARCUSON        


	 	 	 Randall L. Marcuson
 President and Chief Executive Officer




		
	 	 	 /s/    DAVID L.
CASTALDI        


	 	 	David L. Castaldi


  

 2
Exhibit 32.2  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Our Glass, Inc. (the Company) on Form 10-QSB for the period ended June 30, 2007(the Report), I, Cosmo Palmieri, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1) The Report fully complies with the requirement of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and 2) The information contained in the Report fairly presents, in all material respects, the Company's financial position and results of operations. Date: April 4, 2008 /s/ Cosmo Palmieri Chief Financial Officer
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 1 of 14 PageID 1
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 2 of 14 PageID 2
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 3 of 14 PageID 3
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 4 of 14 PageID 4
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 5 of 14 PageID 5
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 6 of 14 PageID 6
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 7 of 14 PageID 7
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 8 of 14 PageID 8
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 9 of 14 PageID 9
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 10 of 14 PageID 10
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 11 of 14 PageID 11
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 12 of 14 PageID 12
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 13 of 14 PageID 13
Case 1:06-cv-00011-C Document 1 Filed 01/23/06 Page 14 of 14 PageID 14
```

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 97 Introduced in House (IH)]

<DOC>

119th CONGRESS
  1st Session
H. RES. 97

 Expressing support for the designation of the week beginning February 
    3, 2025, as ``National Tribal Colleges and Universities Week''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 4, 2025

  Ms. Davids of Kansas submitted the following resolution; which was 
      referred to the Committee on Oversight and Government Reform

_______________________________________________________________________

                               RESOLUTION

 
 Expressing support for the designation of the week beginning February 
    3, 2025, as ``National Tribal Colleges and Universities Week''.

Whereas there are 34 Tribal colleges and universities operating on more than 90 
        campuses in 16 States;
Whereas Tribal colleges and universities are institutions of higher education 
        that receive Tribal charters or Federal charters and therefore have a 
        unique relationship with the Federal Government;
Whereas Tribal colleges and universities serve students from more than 230 
        federally recognized Indian Tribes;
Whereas Tribal colleges and universities offer students access to knowledge and 
        skills grounded in cultural traditions and values, including indigenous 
        languages, which--

    (1) enhance Indian communities; and

    (2) enrich the United States as a nation;

Whereas Tribal colleges and universities provide access to high-quality 
        postsecondary educational opportunities for--

    (1) American Indians;

    (2) Alaska Natives; and

    (3) other individuals who live in some of the most isolated and 
economically depressed areas in the United States;

Whereas Tribal colleges and universities are accredited institutions of higher 
        education that prepare students to succeed in the global and highly 
        competitive workforce;
Whereas Tribal colleges and universities have open enrollment policies, and 
        approximately 13 percent of the students at Tribal colleges and 
        universities are non-Indian individuals; and
Whereas the collective mission and the considerable achievements of Tribal 
        colleges and universities deserve national recognition: Now, therefore, 
        be it
    Resolved, That the House of Representatives--
            (1) supports the designation of ``National Tribal Colleges 
        and Universities Week''; and
            (2) urges the people of the United States and interested 
        groups to observe National Tribal Colleges and Universities 
        Week with appropriate activities and programs to demonstrate 
        support for Tribal colleges and universities.
                                 <all>
```
CERTIFICATION OF


CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER






PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002






I, Anthony Jackson, the, Chief Financial Officer of Empirical Ventures, Inc. (the “Company”), hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:




(i)
the Quarterly Report on Form 10-Q of the Company, for the period ended March 31, 2011, and to which this certification is attached as Exhibit 32 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and(ii)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





By:
/s/ Anthony JacksonName:
Anthony JacksonTitle:
Chief Financial OfficerDate:
March 6, 2014




A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.






This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.
```

[Federal Register Volume 90, Number 9 (Wednesday, January 15, 2025)]
[Notices]
[Page 3886]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-00687]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Heart, Lung, and Blood Initial Review Group; 
NHLBI Mentored Patient-Oriented Research Study Section.
    Date: February 20-21, 2025.
    Time: 9:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge I, 6705 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Fungai Chanetsa, MPH, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 206-B, Bethesda, MD 20817, (301) 402-9394, email: 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-00687 Filed 1-14-25; 8:45 am]
BILLING CODE 4140-01-P
```
Keith Deontay LOVE, Appellant, v. STATE of Florida, Appellee.

No. 1D17-4055

District Court of Appeal of Florida, First District.

May 3, 2019

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.